2-硝基-5-羟基苯甲腈 | 13589-74-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 中文名称: 2-硝基-5-羟基苯甲腈
• 英文名称: 5-hydroxy-2-nitrobenzonitrile
• 英文别名: 5-hydroxy-2-nitrobenzenecarbonitrile
• CAS: 13589-74-7
• 化学式: C₇H₄N₂O₃
• 分子量: 164.12
• InChiKey: IVDZYHBBWXCWGN-UHFFFAOYSA-N

物化性质

• 熔点：
  119-120 °C
• 沸点：
  398.2±37.0 °C(Predicted)
• 密度：
  1.49±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  89.8
• 氢给体数：
  1
• 氢受体数：
  4

安全信息

• 海关编码：
  2926909090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 5-hydroxy-2-nitrobenzonitrile
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 5-hydroxy-2-nitrobenzonitrile
CAS number: 13589-74-7

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C7H4N2O3
Molecular weight: 164.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-硝基-5-羟基苯甲腈 在 palladium on activated charcoal 吡啶 、 喹啉 、 sodium hydroxide 、 silver carbonate 、 氢气 作用下， 以 乙酸乙酯 、 丙酮 为溶剂， 25.0 ℃ 、101.33 kPa 条件下， 反应 18.0h， 生成 (2S,3S,4S,5R,6S)-6-[3-cyano-4-[[4-(diethoxyphosphorylmethyl)benzoyl]amino]phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
  参考文献：
  名称：

  4-[（（4-溴-2-氰基苯基）氨基甲酰基]苄基膦酸二乙酯（NO-1886）的合成及生物活性。

  摘要：

  合成了4-[（4-溴-2-氰基苯基）氨基甲酰基]苄基膦酸二乙酯（NO-1886）（1）的五种代谢物，以证实它们的结构。发现代谢物（2-6）与合成的化合物相同。将这些代谢物口服给予Triton WR-1339诱导的高甘油三酸酯血症大鼠，并测量血浆甘油三酸酯水平以估计脂蛋白脂酶活性。所有的代谢物均显示出比NO-1886更低的效力。

  DOI：

  10.1248/cpb.44.547
• 作为产物：
  描述：

  5-氯-2-硝基苯甲腈 在 potassium acetate 、 sodium hydroxide 、 盐酸 作用下， 以 乙腈 、 水 为溶剂， 反应 16.0h， 生成 2-硝基-5-羟基苯甲腈
  参考文献：
  名称：

  2-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of use

  摘要：

  选定的化合物对于治疗疾病，如细胞增殖或凋亡介导的疾病，具有有效性。该发明涵盖了新颖的化合物、类似物、前药和其药学上可接受的衍生物，药物组合物以及预防和治疗涉及中风、癌症等疾病和其他疾病或病症的方法。该发明还涉及制备这些化合物的方法，以及在这些方法中有用的中间体。

  公开号：

  US20030229068A1

文献信息

• Substituted phenyl sulfonamides as selective .beta. 3 agonists for the
  申请人：Merck & Co., Inc.

  公开号：US05451677A1

  公开（公告）日：1995-09-19

  Substituted phenylsulfonamides are selective .beta..sub.3 adrenergic receptor agonists with very little .beta..sub.1 and .beta..sub.2 adrenergic receptor activity and as such the compounds are capable of increasing lipolysis and energy expenditure in cells. The compounds thus have potent activity in the treatment of Type II diabetes and obesity. The compounds can also be used to lower triglyceride levels and cholesterol levels or raise high density lipoprotein levels or to decrease gut motility. In addition, the compounds can be used to reduced neurogenic inflammation or as antidepressant agents. The compounds are prepared by coupling an aminoalkylphenyl-sulfonamide with an appropriately substituted alkyl epoxide. Compositions and methods for the use of the compounds in the treatment of diabetes and obesity and for lowering triglyceride levels and cholesterol levels or raising high density lipoprotein levels or for increasing gut motility are also disclosed.

  取代苯磺酰胺是选择性的β3肾上腺素受体激动剂，几乎没有β1和β2肾上腺素受体活性，因此这些化合物能够增加细胞内脂解和能量消耗。因此，这些化合物在治疗2型糖尿病和肥胖症方面具有强大的活性。这些化合物还可以用于降低甘油三酯水平和胆固醇水平，或提高高密度脂蛋白水平，或减少肠道蠕动。此外，这些化合物可以用于减少神经源性炎症或作为抗抑郁剂。这些化合物是通过将氨基烷基苯磺酰胺与适当取代的烷基环氧化合物偶联而制备的。还公开了这些化合物在治疗糖尿病和肥胖症以及降低甘油三酯水平和胆固醇水平或提高高密度脂蛋白水平或增加肠道蠕动方面的用途的组合物和方法。
• Studies on the two-phase nitration of phenols (part 2)
  作者：Malcolm J. hompson、Petrus J. eegers

  DOI：10.1016/s0040-4020(01)82044-5

  日期：1990.1

  Gas phase Ionization Potentials can be correlated with solution Oxidation Potentials for phenols and used to predict the likelihood of successful nitration using the two-phase procedure. The interaction of steric and electronic effects then determines the sites of nitration by radical recombination of the phenoxy radical and NO2. Nitration of dioxybenzenes may give insights into the nitration mechanism

  气相电离势可与酚的溶液氧化势相关，并用于预测使用两相过程成功硝化的可能性。然后，空间效应和电子效应的相互作用通过苯氧基与NO 2的自由基复合来确定硝化的位点。硝化二氧苯可能提供有关硝化机理的见解
• Selective nitration of phenol derivatives
  申请人：Junsei Chemical Co., Ltd.

  公开号：US05847231A1

  公开（公告）日：1998-12-08

  Process for preparing 4-nitrophenol derivatives of formula (IV) with high selectivity, which comprises converting phenols to diphenyl oxalate derivatives of formula (III) and conducting nitration reaction and hydrolysis to give said 4-nitrophenol derivatives. ##STR1## In the above formulae, R is, the same or different from each other, an alkyl group having 1 to 4 carbon atoms; a halogen atom; an alkoxy group having 1 to 4 carbon atoms; a formyl group; a nitrile group; --COOR.sup.1 (R.sup.1 is an alkyl group having 1 to 4 carbon atoms); --CONR.sup.2 R.sup.3 (R.sup.2 and R.sup.3 are, the same or different from each other, hydrogen atom(s) or alkyl group(s) having 1 to 4 carbon atoms); or --COR.sup.4 (R.sup.4 is an alkyl group having 1 to 4 carbon atoms), and R is not substituted at the 4-position of the phenyl ring and not substituted at the 2- and 6-positions of the phenyl ring at the same time, and, n is 1, 2 or 3.

  制备具有高选择性的4-硝基苯酚衍生物（IV）的过程，包括将苯酚转化为配方（III）的二苯基草酸酯衍生物，然后进行硝化反应和水解以得到所述的4-硝基苯酚衍生物。在上述公式中，R是1至4个碳原子的同一或不同的烷基基团；卤素原子；1至4个碳原子的同一或不同的烷氧基团；甲酰基团；腈基团；-COOR^1（R^1是1至4个碳原子的烷基基团）；-CONR^2R^3（R^2和R^3是同一或不同的氢原子或1至4个碳原子的烷基基团）；或-COR^4（R^4是1至4个碳原子的烷基基团），且R在苯环的4位不被取代，在2位和6位同时不被取代，n为1、2或3。
• Amidino substituted 2-aminophenols: biologically important building blocks for the amidino-functionalization of 2-substituted benzoxazoles
  作者：Lucija Ptiček、Lucija Hok、Petra Grbčić、Filip Topić、Mario Cetina、Kari Rissanen、Sandra Kraljević Pavelić、Robert Vianello、Livio Racané

  DOI：10.1039/d1ob00235j

  日期：——

  Pinner synthesis of the crucial carboximidate intermediates was characterized through mechanistic DFT calculations, with the obtained kinetic and thermodynamic parameters indicating full agreement with the experimental observations. The obtained amidines were subjected to a condensation reaction with aryl carboxylic acids that allowed the synthesis of a new library of 5- and 6-amidino substituted 2-arylbenzoxazoles

  与密切相关且经过广泛研究的具有一系列已证明的生物活性的a基取代的苯并咪唑和苯并噻唑不同，相匹配的苯并恶唑类似物仍然在很大程度上未被研究，并且没有得到系统的评估。为了解决这一挑战，我们利用Pinner反应将同分异构的氰基取代的2-氨基酚转化为into衍生物，将其分离为盐酸盐和/或两性离子，并通过单晶X射线衍射证实了其结构。通过机械DFT计算表征了关键的羧酰亚胺中间体的Pinner合成过程中的关键步骤，获得的动力学和热力学参数表明与实验结果完全吻合。将获得的am与芳基羧酸进行缩合反应，从而可以合成5-和6​​--基取代的2-芳基苯并恶唑的新文库。它们对四种人类肿瘤细胞系（SW620，HepG2，CFPAC-1，HeLa）的抗增殖特性表明，SW620对几种环状a基2-萘基苯并恶唑具有亚微摩尔活性，从而证明了拟议的合成策略的有用性并促进了mid基取代的2 -氨基酚是生物活性系统的重要组成部分。
• GLUCOKINASE ACTIVATORS
  申请人：Feng Jun

  公开号：US20070244169A1

  公开（公告）日：2007-10-18

  Compounds, pharmaceutical compositions, kits and methods are provided for use with glucokinase that comprise a compound selected from the group consisting of: wherein the variables are as defined herein.

  本发明提供了用于与葡萄糖激酶一起使用的化合物、制药组合物、试剂盒和方法，其中包括所述化合物中选自以下组的化合物：其中所述变量如本文所定义。